Ireland
--:--IST
Starting soon Observational

AI-assisted Tracheal Intubation in Children

NCT07922434 · tracked via the Priya Life Science Switzerland tracker
Phase
Observational
Started
2026-11
Last updated
2026-11-06

Condition(s) studied

Intubation

Investigational drug(s) / intervention(s)

LarynGuide

LarynGuide: Artificial Intelligence assisted tracheal video intubation in children

Study summary

The aim of this study is to investigate whether the use of larynGuide™ provides accurate and reliable information regarding the position of the endotracheal tube following an intubation attempt in children. larynGuide™ is a software tool that runs on a video laryngoscope platform to assist with laryngoscopy and intubation.

Eligibility

Sex
ALL
Min age
6 Months
Max age
6 Years
Healthy volunteers
No
Inclusion Criteria: * male or female pediatric patients ≥ 6 months to ≤ 6 years, * American Society of Anesthesiologists (ASA) class I to III * undergoing elective surgery in general anaesthesia with tracheal intubation. Exclusion Criteria: * Contraindication for intubation with C-MAC video laryngoscope (Karl Storz, Tuttlingen, Germany) * Patients \< 6 months or \> 6 years * No proper trained personnel for the device at the study site * Expected impossible mask ventilation. * High risk of aspiration (requiring rapid sequence induction and intubation) * Intracranial surgery * Limited knowledge of German language or refusing informed consent.

Primary outcome measure(s)

  • Rate of correct assessment given by larynGuide™ — 5 minutes
    Correctness of the advice measured by accuracy of the LarynGuide™, a software for artificial intelligence assisted tracheal intubation (aiEndoscopic, Zürich, Switzerland) on tube position given at the end of an intubation attempt

Trial sites (1)

FacilityCityRegionStatus
Inselspital Bern Canton of Bern
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07922434 on ClinicalTrials.gov ↗ ← All trials in Switzerland